Anti-Hu CD94 PE

*Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park IK, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA: CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood. 2010 Jan 14;115 (2) :274-81, URL: http://www.ncbi.nlm.nih.gov/pubmed/19897577 , *Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL: CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity. 1996 Aug;5 (2) :163-72., URL: http://www.ncbi.nlm.nih.gov/pubmed/8769479 , *Seo N, Tokura Y, Ishihara S, Takeoka Y, Tagawa S, Takigawa M: Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites. Clin Exp Immunol. 2000 Jun;120 (3) :413-9., URL: http://www.ncbi.nlm.nih.gov/pubmed/10844517 , *Hallermalm K, Seki K, De Geer A, Motyka B, Bleackley RC, Jager MJ, Froelich CJ, Kiessling R, Levitsky V, Levitskaya J: Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes. J Immunol. 2008 Mar 15;180 (6) :3766-74., URL: http://www.ncbi.nlm.nih.gov/pubmed/18322182 , *Bovenschen HJ, Van De Kerkhof PC, Gerritsen WJ, Seyger MM: The role of lesional T cells in recalcitrant psoriasis during infliximab therapy. Eur J Dermatol. 2005 Nov-Dec;15 (6) :454-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/16280298 , *Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod. 2001 May;16 (5) :855-61., URL: http://www.ncbi.nlm.nih.gov/pubmed/11331628 , *Romero P, Ortega C, Palma A, Molina IJ, Peñ a J, Santamaría M: Expression of CD94 and NKG2 molecules on human CD4 (+) T cells in response to CD3-mediated stimulation. J Leukoc Biol. 2001 Aug;70 (2) :219-24., URL: http://www.ncbi.nlm.nih.gov/pubmed/11493613, *Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K: The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur J Immunol. 2004 Jan;34 (1) :81-90., URL: http://www.ncbi.nlm.nih.gov/pubmed/14971033